Table 3.
Multivariate Cox Regression Analysis for OS
Multivariate Analysis | |||||
---|---|---|---|---|---|
Model 1 | Model 2 | ||||
Characteristics | HR (95% CI) | p- value | HR (95% CI) | p- value | |
∆CEA% | < −30.29% vs > −30.29% | 0.558 (0.259–1.201) | 0.136 | ||
∆CA199% | < 20.30% vs > 20.30% | 0.468 (0.220–0.994) | 0.048 | ||
STBC score | 0 vs 1–2 | 0.204 (0.078–0.532) | 0.001 | ||
ypT staging | (0–2) vs (3–4) | 0.420 (0.182–0.970) | 0.042 | 0.426 (0.184–0.986) | 0.046 |
ypN staging | Negative vs positive | 0.680 (0.315–1.465) | 0.324 | 0.574 (0.269–1.226) | 0.152 |
Notes: Model 1, ∆CEA% and ∆CA199% were included in multivariate analysis, STBC score was not. Model 2: STBC score was in multivariate analysis, ∆CEA% and ∆CA199% were not.
Abbreviations: yp, pathologic status after neoadjuvant chemoradiotherapy; ∆CEA %, (post-chemoradiotherapy CEA – pre-chemoradiotherapy CEA)/pre-chemoradiotherapy CEA*100%; ∆CA199 %, (post-chemoradiotherapy CA199 – pre-chemoradiotherapy CA199)/ pre-chemoradiotherapy CA199*100%; STBC score, serum tumor biomarkers change score.